EUCOPE

Giving a bigger voice to small and mid-sized innovative #pharma #biotech #medtech companies in Europe

🎧Sounds of Science Podcast:

[EUCOPE @EUCOPE]

🎙️ New #SoundsOfScience episode!
#AMR – the “silent killer” – is on the rise. How can the #EU turn the tide?
EUCOPE latest podcast talks incentives, innovation & action on #antimicrobials.
🎧 Listen now: https://t.co/eeGGn28Uoi
#HealthPolicy #Antibiotics #EUHealth

[The Parliament Events @parlimagevents]

📅 Rare Diseases Forum 2026 | Brussels

30 million Europeans. Multiple EU initiatives. Major legislative reform underway. Yet access to diagnosis and treatment for rare diseases remains uneven, and coordination across borders fragile.

On 21 April, the focus turns to the policy decisions that will shape the next phase of EU action. Join our Rare Diseases Forum in Brussels, with MEPs @BosseStine and @nicogoncas e and many others.

Take part in the debate: https://t.co/LbOk3woaar

@ChiesiGroup, @AlexionPharma, @Amgen, @sanofi, @ultragenyx, @PTCBio, @EUCOPE, @eurordis

[EUCOPE @EUCOPE]

📩EUCOPE's Innovation Eye-View - Q2 2025 - https://t.co/G2GiKcchfT

[EUCOPE @EUCOPE]

📩EUCOPE's Innovation Eye-View - Q2 2025 - https://t.co/G2GiKcchfT

[EU Perspectives @EUPerspectives]

🎥 Lights, mics, and EU health policy.

We are already in the @Europarl_EN preparing the next episode of the EU Perspectives podcast

Take a sneak peek behind the scenes👀

We’re diving into two of the biggest issues in EU healthcare today:
➡️ The Critical Medicines Act
➡️ Multiannual Financial Framework

🎙️ With expert voices:
• @VeronikaCifrova (MEP, @RenewEurope )
• Arnaud Maheas (Head of Public Affairs Europe at Sandoz and  & Chair of @medicinesforEU market access committee)
• Stefano Romanelli (Senior Government Affairs Manager from @EUCOPE )

📺 Full episode coming soon, stay tuned!

#EUPerspectives #Podcast #EUhealthcare #PharmaPolicy #HealthPolicy

[EUCOPE @EUCOPE]

🚨 New EUCOPE Member Spotlight:

🧪For 15+ years, @ultragenyx focuses on #rarediseases, using a dynamic development model and collaboration with families to accelerate innovation in life-changing treatments.
👉Learn more from SVP Jane Cooper: https://t.co/8W82QiMwmK

[EUCOPE @EUCOPE]

EUCOPE reacts to Council deal on #EUPharmaPackage:
It's a step forward, but #innovation must remain a priority. The trilogue negotiators need to deliver a future-proofed, innovation-friendly framework.
Read more: https://t.co/QaYTxidsEL
#LifeSciences #EUPharma

[EUCOPE @EUCOPE]

As the EU enters a new legislative cycle, #EUCOPE sets out its vision for the future of #HERA.
To build a resilient #PreparednessUnion, we outline 6 priorities—from innovation & funding to coordination & public-private partnerships:
👉https://t.co/WIhlCbF0ND
#EUHealth #MFF2027

[EUCOPE @EUCOPE]

🌍 On 24 May, the #WHA77 adopted a historic resolution on #RareDiseases.
💬 “The #EU should seize this chance to lead globally and deliver real change for #RareDisease #patients.” — Sarah Khor, @Amgen
📄 Read more:https://t.co/8Rv0wK64cP

[EUCOPE @EUCOPE]

Watch now the full recording of #EUCOPE's webinar: "Implementing the #EuropeanHealthDataSpace – The Next Steps" 👉https://t.co/SrrFkWN5kn
In a dynamic session, EU policymakers, legal experts, and industry leaders explored the practical aspects of #EHDS implementation.

[EUCOPE @EUCOPE]

🎙️ Sounds of Science | #EU Biotech Act: How to ensure the biopharmaceutical sector thrives in the EU
EUCOPE joins J. Grames - AOP Health & E. Gicquel -Miltenyi Biomedicine to unpack the #BiotechAct & its impact on #innovation.
🔗 Listen now: https://t.co/awNVfYRW7o
#EUHealth

[EUCOPE @EUCOPE]

💡This month, we connected with Muriel O'Byrne, Senior VP and Head of International Reg. Affairs and the European Business Office at @Regeneron
👉Read the full Q&A here: https://t.co/fvMu3ulHQX
#Pharma #HealthcareInnovation #PatientAccess #EUHealth #ATMPs #EUCOPE

[EUCOPE @EUCOPE]

Join the EUCOPE Life Science Lecture Webinar: Implementing the European Health Data Space (#EHDS) – The Next Steps
🗓️ 6 May 2025
🕒 15:00–16:00 CEST
📄 Read the agenda: https://t.co/91OujfavUg
📨 Register now: https://t.co/l5rJLHtccg

[EUCOPE @EUCOPE]

📢 EUCOPE policy brief outlines:
✅ The potential of #LiquidbBiopsy in #CancerCare
✅ The benefits for healthcare systems
✅ Country-level insights into access and reimbursement
✅ Key policy recommendations to support adoption across the #EU
Read more: https://t.co/2fSZ1teThH

[EUCOPE @EUCOPE]

Read now the EUCOPE and @IFPMA joint statement supporting the Call to Action published by the 245 organisations calling on the #WorldHealthAssembly to adopt its resolution calling for a #GlobalRareDiseaseActionPlan.
👉 https://t.co/TJXzOd1ZE9

#LifeScienceStrategy #BiotechAct

[EUCOPE @EUCOPE]

📩EUCOPE's Innovation Eye-View - Q1 2025 - https://t.co/LzCjAhWszc

[EUCOPE @EUCOPE]

📩EUCOPE's Innovation Eye-View - Q1 2025 - https://t.co/LzCjAhWszc

[EUCOPE @EUCOPE]

#EUCOPEMemberSpotlight
We had the pleasure of speaking with Corinne Schmitz, Chairman, Founder, and CEO of #AzurBioPharma, touching on #PatientAccess, #InnovativeTherapies, the #EU regulatory landscape, and #InvestmentChallenges.
Read more: https://t.co/wRihT8JfFt

[EUCOPE @EUCOPE]

🚀 #Sustainability & #HealthEquity are reshaping @MarketAccess in the #EU.
Stay ahead with @AliraHealth’s webinar: learn how policy shifts are changing payer expectations & strategies.
👉More information: https://t.co/eeh7gFmcdE

[EUCOPE @EUCOPE]

Join EUCOPE's in-person workshop: 'How to prepare for EU HTA from a Payer Perspective'
🗓️ Thursday 8 May 2025
⏰ 11:00 to 17:00 CET
📍 Brussels
Learn how to navigate the impact of #EUHTA on pharmaceutical market access in Europe.
Registration: https://t.co/KZZlRrJ85d